Global Cell and Tissue Supplies Market: Snapshot
Cell and tissue culture refers to the process of removing cells and tissues from a plant or an animal and subsequently growing them in controlled artificial environment with conducive temperature, nutrition, and humidity conditions. The process of separating the cells or tissues from their natural environment and shifting them to an artificial environment, called cultivation, involves removing the cell/tissues directly and disaggregating by a mechanical or enzymatic procedure or deriving them from an artificially established cell line.
Over the past several decades of continuous developments, cell culture has emerged as one of the key tools used in molecular and cellular biology to study cell physiology, effects of toxins and various drugs on cells, and biochemistry, mutagenesis, and carcinogenesis of cells. Cell and tissue cultures are also used for the large scale production of biological compounds such as therapeutic proteins and vaccines, and for the screening and development of a variety of therapeutic drugs. The advantage of being able to obtain consistent results from the use of a batch of cultured cells continues to encourage the increased usage of cell and tissue culture for such applications.
This report on the global market for cell and tissue supplies presents a detailed overview of the present state of the market and verifiable projections regarding the future growth prospects of the market and its key segments. Market’s deliverables include a variety of products such as bioreactors, petri-dishes, spreaders, culture cylinders, scrapers and lifters, tissue grinders, syringe filters, and serological pipettes, commonly used for undertaking a number of operations associated with cell and tissue cultures.
Global Cell and Tissue Supplies Market: Trends and Opportunities
The global market of cell and tissue supplies is chiefly driven due to the rising demand for artificial organs and biopharmaceutical products across the globe. The vast rise in importance of cell culture technologies in the fields of research and development of a vast variety of therapeutics and bimolecular elements is further fueling the global demand for cell and tissue supplies. The key end users of cell and tissue supplies include biotechnology companies, commercial cell culture laboratories, and pharmaceutical companies.
The market is also significantly benefiting from the development of specialty growth media and culture techniques, which ensure specificity and availability of high-end technology for scaling up cultures. However, ethical concerns over the use of animal sources for cell culture is expected to hamper the growth prospects of the market to a certain extent in the next few years.
Global Cell and Tissue Supplies Market: Geographical and Competitive Dynamics
In terms of geography, the global cell and tissue supplies market is led by North America. The dominance of the region in this sector is attributed to the vast advancements in cell culture tools in the past few years. Additionally, the rising demand for animal component-free media and the increased demand for automated cell culture systems is expected to further boost the demand for cell culture supplies in North America. Europe is also one of the leading consumers of cell and tissue culture supplies owing to the high concentration of pharmaceutical and biotechnology companies and cell culture researchers in the region. However, Asia-Pacific is expected to emerge as the most promising regional market for cell and tissue suppliers in the next few years. The report presents a thorough analytical overview of the competitive landscape of the market with detailed business profiles of leading cell and tissue supplies manufacturers such as Sigma-Aldrich Co. LLC., STEMCELL Technologies, Capitol Scientific, Inc., Biocompare, Wheaton Industries, Inc., and GE Healthcare Ltd., and VWR International, LLC.